Virchow is the first Indian biotech player to get an ANVISA approval and INVIMA
approval for recombinant products. Given this great regulatory strength, Virchow
has been able to expand quickly in international markets and has already gained
access to Ukraine, Russia, Brazil, Colombia, Turkmenistan, Cambodia, Myanmar, Sri
Lanka, Philippines, Uganda, and Kenya.